Publication
7/15/2021
Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.
Sims JJ, Greig JA, Michalson KT, Lian S, Martino RA, Meggersee R, Turner KB, Nambiar K, Dyer C, Hinderer C, Horiuchi M, Yan H, Huang X, Chen SJ, Wilson JM
Plos Pathogens
Publication
9/16/2020
Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations.
Hinderer C, Miller R, Dyer C, Johansson J, Bell P, Buza E, Wilson JM
Annals Of Clinical And Translational Neurology
Publication
7/31/2020
Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology
Hordeaux J, Buza EL, Dyer C, Goode T, Mitchell TW, Richman L, Denton N, Hinderer C, Katz N, Schmid R, Miller R, Choudhury GR, Horiuchi M, Nambiar K, Yan H, Li M, Wilson JM
Human Gene Therapy
Publication
4/18/2020
Translational Feasibility of Lumbar Puncture for Intrathecal AAV Administration.
Hinderer C, Katz N, Dyer C, Goode T, Johansson J, Bell P, Richman L, Buza E, Wilson JM
Molecular Therapy. Methods & Clinical Development
Publication
3/01/2018
Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.
Hinderer C, Katz N, Buza EL, Dyer C, Goode T, Bell P, Richman LK, Wilson JM
Human Gene Therapy
